Skip to main content

MGP INGREDIENTS INC

For the period ended Mar 31, 2025. Filed May 1, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 1, 2025

MGPI$17.12-0.5%Stored close · as of Oct 30, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Quarter to Date Ended March 31,
20252024
Cash Flows from Operating Activities
Net income (loss)$(3,057)$20,584
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization5,8085,289
Share-based compensation7421,116
Equity method investment loss (gain)(257)296
Deferred income taxes, including change in valuation allowance64645
Change in fair value of contingent consideration14,7004,100
Other, net73157
Changes in operating assets and liabilities:
Receivables, net40,59411,257
Inventory(13,439)(2,119)
Prepaid expenses(1,025)(1,904)
Income taxes payable (refundable)(2,094)5,530
Accounts payable(146)(10,207)
Accrued expenses and other2,857(10,380)
Federal and state excise taxes payable(98)1,548
Other, net(38)(1,289)
Net cash provided by operating activities44,68424,623
Cash Flows from Investing Activities
Additions to property, plant, and equipment(19,926)(27,026)
Other, net—(240)
Net cash used in investing activities(19,926)(27,266)
Cash Flows from Financing Activities
Payment of dividends and dividend equivalents(2,578)(2,672)
Repurchase of Common Stock(1,035)(6,961)
Proceeds from long-term debt—30,000
Principal payments on long-term debt(26,600)(16,600)
Net cash provided by (used in) financing activities(30,213)3,767
Effect of exchange rate changes on cash and cash equivalents294(15)
Increase (decrease) in cash and cash equivalents(5,161)1,109
Cash and cash equivalents, beginning of period25,27318,388
Cash and cash equivalents, end of period$20,112$19,497
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.